At a glance - Novozymes’ strategy, ambition and businesses

Get a quick investor overview of Novozymes – read about our strategy, ambition, and business areas.

Novozymes in a nutshell

Novozymes is the world leader in bioinnovation, producing a wide range of industrial enzymes, microorganisms, and biopharmaceutical ingredients. We are a unique biotech company with a strong track record for delivering growth based on innovation. We operate a triple bottom line and are thus committed to continuously improving our financial, environmental, and social performance.

Below you can read about our two business areas. Read more about Novozymes’ strategy here or check out our long-term ambition. For a quick overview of the company, please see our investor fact sheet.

For investors: Novozymes' business areas
Enzyme Business

The development, production, and distribution of enzymes form the major part of our business, currently accounting for 90% of sales. Enzymes are readily biodegradable proteins found in all living organisms with the ability to catalyze biochemical reactions. Enzyme technologies can typically replace conventional chemicals, improving resource efficiency and generally reducing environmental impact. Read more about the sustainability benefits of biotechnology. 

BioBusiness

BioBusiness builds on the technological capabilities and competencies of Enzyme Business. BioBusiness was formed with the purpose of exploring biological business opportunities outside the enzyme sphere, by leveraging the expertise gained working with biotech and enzymes for more than 60 years.
We see a lot of opportunities to use our existing technologies to broaden the range of applications within BioBusiness, and we consider BioBusiness to be a portfolio of growth opportunities for the future.